$291 Million is the total value of Sio Capital Management, LLC's 64 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 118.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $14,620,000 | – | 363,960 | +100.0% | 5.02% | – |
| CI | Buy | CIGNA CORP | $14,046,000 | +110.8% | 67,449 | +72.1% | 4.82% | +30.8% |
| PCRX | New | PACIRA PHARMACEUTICALS INCput | $13,816,000 | – | 281,100 | +100.0% | 4.74% | – |
| KURA | Sell | KURA ONCOLOGY INC | $12,727,000 | -16.5% | 727,258 | -13.2% | 4.37% | -48.2% |
| AET | Buy | AETNA INC | $12,261,000 | +70.7% | 60,444 | +54.4% | 4.21% | +6.0% |
| SNY | Buy | SANOFI SAsponsored adr | $11,900,000 | +98.2% | 266,388 | +77.5% | 4.08% | +23.0% |
| HCA | Sell | HCA HEALTHCARE INC | $11,661,000 | +16.9% | 83,822 | -13.8% | 4.00% | -27.5% |
| AMGN | New | AMGEN INCput | $10,365,000 | – | 50,000 | +100.0% | 3.56% | – |
| MEIP | Buy | MEI PHARMA INC | $9,929,000 | +15.4% | 2,303,645 | +5.5% | 3.41% | -28.4% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $9,117,000 | +210.3% | 104,176 | +249.2% | 3.13% | +92.6% |
| BNGO | New | BIONANO GENOMICS INC*w exp 08/21/2023 | $7,353,000 | – | 1,440,857 | +100.0% | 2.52% | – |
| UROV | New | UROVANT SCIENCES LTD | $7,097,000 | – | 591,454 | +100.0% | 2.44% | – |
| BIIB | New | BIOGEN INC | $6,819,000 | – | 19,300 | +100.0% | 2.34% | – |
| ANTM | Sell | ANTHEM INC | $6,797,000 | -34.5% | 24,803 | -43.1% | 2.33% | -59.4% |
| HUM | Buy | HUMANA INC | $6,789,000 | +28.2% | 20,054 | +12.7% | 2.33% | -20.5% |
| PINC | New | PREMIER INCcl a | $6,611,000 | – | 144,412 | +100.0% | 2.27% | – |
| XRAY | New | DENTSPLY SIRONA INCput | $6,416,000 | – | 170,000 | +100.0% | 2.20% | – |
| MRK | New | MERCK & CO INCcall | $5,959,000 | – | 84,000 | +100.0% | 2.04% | – |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $5,940,000 | +8.0% | 550,977 | +16.9% | 2.04% | -33.0% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $5,918,000 | +49.5% | 1,843,501 | +31.8% | 2.03% | -7.2% |
| UHS | Buy | UNIVERSAL HEALTH SERVICES INCcl b | $5,292,000 | +34.5% | 41,393 | +17.2% | 1.82% | -16.5% |
| SNN | New | SMITH & NEPHEW PLCspdn adr new | $4,984,000 | – | 134,388 | +100.0% | 1.71% | – |
| NVS | Buy | NOVARTIS AGsponsored adr | $4,971,000 | +19.6% | 57,691 | +4.9% | 1.71% | -25.7% |
| AMAG | New | AMAG PHARMACEUTICALS INCput | $4,524,000 | – | 226,200 | +100.0% | 1.55% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $4,412,000 | – | 770,000 | +100.0% | 1.51% | – |
| PHG | Sell | KONINKLIJKE PHILIPS NVny reg sh new | $4,359,000 | +1.3% | 95,776 | -5.9% | 1.50% | -37.1% |
| AMGN | New | AMGEN INCcall | $4,146,000 | – | 20,000 | +100.0% | 1.42% | – |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $4,084,000 | +46.9% | 164,353 | +62.3% | 1.40% | -8.8% |
| VKTX | Sell | VIKING THERAPEUTICS INC | $3,715,000 | +39.1% | 213,252 | -24.2% | 1.28% | -13.6% |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $3,584,000 | – | 25,785 | +100.0% | 1.23% | – |
| ICLR | Sell | ICON PLC | $3,567,000 | -51.4% | 23,198 | -58.1% | 1.22% | -69.8% |
| STRO | New | SUTRO BIOPHARMA INC | $3,488,000 | – | 232,539 | +100.0% | 1.20% | – |
| MDT | New | MEDTRONIC PLC | $3,462,000 | – | 35,196 | +100.0% | 1.19% | – |
| AZN | New | ASTRAZENECA PLCput | $3,458,000 | – | 87,400 | +100.0% | 1.19% | – |
| CAH | Sell | CARDINAL HEALTH INC | $3,348,000 | -45.9% | 62,004 | -51.1% | 1.15% | -66.4% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $3,347,000 | +22.2% | 12,579 | +12.7% | 1.15% | -24.2% |
| AGN | New | ALLERGAN PLCput | $3,333,000 | – | 17,500 | +100.0% | 1.14% | – |
| PFE | Sell | PFIZER INCput | $3,151,000 | -13.1% | 71,500 | -28.5% | 1.08% | -46.1% |
| EBS | New | EMERGENT BIOSOLUTIONS INC | $2,752,000 | – | 41,799 | +100.0% | 0.94% | – |
| NVRO | New | NEVRO CORP | $2,570,000 | – | 45,091 | +100.0% | 0.88% | – |
| RMED | New | RA MEDICAL SYSTEMS INC | $2,467,000 | – | 135,553 | +100.0% | 0.85% | – |
| AFMD | New | AFFIMED NV | $2,426,000 | – | 557,615 | +100.0% | 0.83% | – |
| HRC | Buy | HILL-ROM HOLDINGS INC | $2,269,000 | +21.1% | 24,036 | +12.1% | 0.78% | -24.8% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INC | $2,190,000 | – | 114,259 | +100.0% | 0.75% | – |
| CFMS | Buy | CONFORMIS INC | $1,973,000 | -4.0% | 1,861,789 | +13.2% | 0.68% | -40.5% |
| SENS | New | SENSEONICS HOLDINGS INC | $1,919,000 | – | 402,408 | +100.0% | 0.66% | – |
| VICL | New | VICAL INC | $1,699,000 | – | 1,239,813 | +100.0% | 0.58% | – |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $1,559,000 | – | 164,943 | +100.0% | 0.54% | – |
| AKCA | New | AKCEA THERAPEUTICS INCput | $1,516,000 | – | 43,300 | +100.0% | 0.52% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $1,505,000 | – | 32,832 | +100.0% | 0.52% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $1,437,000 | +132.1% | 416,458 | +115.5% | 0.49% | +44.2% |
| ECOR | Sell | ELECTROCORE, INC. | $1,206,000 | -65.8% | 86,120 | -59.6% | 0.41% | -78.7% |
| SPPI | Sell | SPECTRUM PHARMACEUTICALS INC | $1,188,000 | -60.5% | 70,712 | -50.7% | 0.41% | -75.5% |
| PFNX | Buy | PFENEX INC | $1,092,000 | +6.5% | 213,608 | +12.7% | 0.38% | -33.9% |
| ESTA | New | ESTABLISHMENT LABS HOLDINGS INC | $1,077,000 | – | 44,678 | +100.0% | 0.37% | – |
| ABT | New | ABBOTT LABORATORIES | $1,043,000 | – | 14,220 | +100.0% | 0.36% | – |
| TMDI | New | TITAN MEDICAL INC | $949,000 | – | 445,680 | +100.0% | 0.33% | – |
| ACHV | New | ACHIEVE LIFE SCIENCES INC | $523,000 | – | 165,982 | +100.0% | 0.18% | – |
| OPTN | New | OPTINOSE INC | $336,000 | – | 27,068 | +100.0% | 0.12% | – |
| LXRX | New | LEXICON PHARMACEUTICALS INCput | $230,000 | – | 21,600 | +100.0% | 0.08% | – |
| GTXI | New | GTX INCput | $81,000 | – | 51,500 | +100.0% | 0.03% | – |
| VTL | Buy | VITAL THERAPIES INCput | $54,000 | -43.2% | 194,700 | +1300.7% | 0.02% | -64.2% |
| VTL | New | VITAL THERAPIES INC | $29,000 | – | 103,707 | +100.0% | 0.01% | – |
| HSGX | Exit | HISTOGENICS CORP | $0 | – | -39,175 | -100.0% | -0.05% | – |
| CTIC | Exit | CTI BIOPHARMA CORPput | $0 | – | -31,600 | -100.0% | -0.09% | – |
| VSAR | Exit | VERSARTIS INC | $0 | – | -248,653 | -100.0% | -0.28% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -872,406 | -100.0% | -0.31% | – |
| XLRN | Exit | ACCELERON PHARMA INCput | $0 | – | -16,700 | -100.0% | -0.45% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -13,840 | -100.0% | -0.65% | – |
| OMI | Exit | OWENS & MINOR INC | $0 | – | -75,000 | -100.0% | -0.69% | – |
| ZTS | Exit | ZOETIS INCput | $0 | – | -16,000 | -100.0% | -0.75% | – |
| WST | Exit | WEST PHARMACEUTICAL SERVICES INCput | $0 | – | -14,100 | -100.0% | -0.77% | – |
| PINC | Exit | PREMIER INCput | $0 | – | -40,000 | -100.0% | -0.80% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -10,740 | -100.0% | -0.83% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -43,842 | -100.0% | -0.85% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -6,557 | -100.0% | -0.89% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -17,500 | -100.0% | -1.29% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -42,000 | -100.0% | -1.56% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -60,050 | -100.0% | -1.64% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -41,942 | -100.0% | -1.84% | – |
| MYL | Exit | MYLAN NVcall | $0 | – | -100,000 | -100.0% | -2.00% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -52,620 | -100.0% | -2.13% | – |
| WLTW | Exit | WILLIS TOWERS WATSON PLC | $0 | – | -25,969 | -100.0% | -2.18% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -182,633 | -100.0% | -3.30% | – |
| DB | Exit | DEUTSCHE BANK AGput | $0 | – | -654,800 | -100.0% | -3.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.